OTCMKTS:AOXG Aoxing Pharmaceutical (AOXG) Stock Price, News & Analysis → The only AI company you should be looking at (From Behind the Markets) (Ad) Free AOXG Stock Alerts $0.0049 0.00 (0.00%) (As of 03/18/2024 ET) Add Compare Share Share Today's Range$0.0049▼$0.004950-Day Range$0.0047▼$0.013952-Week Range$0.0010▼$0.0139VolumeN/AAverage Volume6,198 shsMarket Capitalization$1.67 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartShort InterestStock AnalysisChartShort Interest Get Aoxing Pharmaceutical alerts: Email Address Ad InvestorPlaceThey said crypto was dead. It went up 100X.Bitcoin’s haters are out again. Despite the price doubling in the last six months alone… That hasn’t stopped the experts from piling on. Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews. JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.” But when it comes to cryptos, these are exactly the people you shouldn’t listen to. They’ve predicted crypto’s demise for years.There are five coins you must take a look at right away. About Aoxing PharmaceuticalAoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People's Republic of China. The company's principal products include Zhongtong'an, a capsule of herbal extraction for the indication of oral and dental pain; and Yiqi Qiangshen Granule, an OTC herbal extraction for tonifying qi and empowering body, and promoting blood circulation to remove meridian obstruction, as well as Tilidine hydrochloride, an orally-absorbed synthetic narcotic analgesic tablet used in 50mg or 100mg dosage for relief of acute, moderate to severe pain, and chronic cancer-related pain. Its products under development comprise Oxycodone and Acetaminophen tablets and capsules, which has completed clinical trials for the treatment of acute and chronic pain; Buprenorphine/Naloxone, a sublingual combo tablet that has completed Phase II clinical trials for the treatment of opioid dependence; and Tilidine/Naloxone, a compound capsule which is in Phase II clinical trial to treat acute and chronic pain. The company was formerly known as China Aoxing Pharmaceutical Company, Inc. and changed its name to Aoxing Pharmaceutical Company, Inc. in March 2010. Aoxing Pharmaceutical Company, Inc. is headquartered in Shijiazhuang, China.Read More AOXG Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AOXG Stock News HeadlinesJanuary 23, 2024 | finance.yahoo.comAoxing Pharmaceutical Company, Inc. (AOXG)December 16, 2023 | morningstar.comAoxing Pharmaceutical Co Inc AOXGMarch 19, 2024 | Crypto 101 Media (Ad)Altcoin FRENZY Alert…Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days… November 23, 2023 | seekingalpha.comOPHLY Ono Pharmaceutical Co., Ltd.July 13, 2022 | benzinga.comAoxing Pharmaceutical Co (OTC:AOXG), Analyst Ratings, Price Targets, PredictionsSee More Headlines Receive AOXG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aoxing Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/16/2016Today3/19/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:AOXG Previous SymbolNYSEMKT:AXN CUSIPN/A CIKN/A Webaxzyen.icm.cn Phone(646) 367-1747Fax646-367-1747Employees346Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares341,210,000Free Float280,474,000Market Cap$1.67 million OptionableNot Optionable Beta6.26 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Zhenjiang Yue (Age 65)Chairman and Chief Executive Officer Comp: $155.32kMr. Guoan Zhang (Age 54)CFO, Chief Accounting Officer & Senior VP of Finance Key CompetitorsSunshine BiopharmaNASDAQ:SBFMAcerus PharmaceuticalsOTCMKTS:ASPCFMallinckrodtOTCMKTS:MNKKQAgile TherapeuticsNASDAQ:AGRXPaxMedicaNASDAQ:PXMDView All Competitors AOXG Stock Analysis - Frequently Asked Questions How have AOXG shares performed in 2024? Aoxing Pharmaceutical's stock was trading at $0.0031 at the beginning of the year. Since then, AOXG stock has increased by 58.1% and is now trading at $0.0049. View the best growth stocks for 2024 here. How were Aoxing Pharmaceutical's earnings last quarter? Aoxing Pharmaceutical Company, Inc. (OTCMKTS:AOXG) announced its earnings results on Monday, May, 16th. The company reported $0.01 earnings per share (EPS) for the quarter. The business had revenue of $6.56 million for the quarter. What other stocks do shareholders of Aoxing Pharmaceutical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Aoxing Pharmaceutical investors own include Agenus (AGEN), Chesapeake Energy (CHKAQ), AcelRx Pharmaceuticals (ACRX), Ballard Power Systems (BLDP), CTI BioPharma (CTIC), Edap Tms (EDAP), Fortress Biotech (FBIO), Inovio Pharmaceuticals (INO) and Pernix Therapeutics (PTX). How do I buy shares of Aoxing Pharmaceutical? Shares of AOXG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:AOXG) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressAltcoin FRENZY Alert…Crypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aoxing Pharmaceutical Company, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.